NuScale Power (NYSE: SMR) shareholders have endured a brutal year, with the stock shedding 86.6% while the broader S&P 500 returned 17.9% over the same period.
That decline is now baked into the current valuation, meaning anyone holding a position today owns the same underlying reality whether they sell or stay.
What that position actually represents is a company with minimal revenue, substantial cash reserves, and a single pending reactor contract in Romania that has yet to be signed.
At the October 15 close, NuScale carried a market value of approximately $2.64 billion, with $1.89 billion of that figure sitting in cash, short-term investments, and longer-dated investments, against zero debt.
That means roughly 72% of the company’s market value is composed of liquid assets, leaving the operating business itself priced at an enterprise value of approximately $750 million.
That cash position is actively shrinking, as NuScale burned through $58.6 million in negative free cash flow during the June quarter alone.
The company moved to replenish its reserves by announcing a $750 million sale of new shares in August, a transaction not reflected in the June quarter figures, though issuing additional shares dilutes existing shareholders.
On the revenue side, the picture is stark, with NuScale posting just $75,000 in sales during the June quarter, compared to $8.05 million in the same period a year earlier.
Executives explained on the August 5 earnings call that the decline reflects the completion of design work for Fluor on the RoPower project in late 2025, leaving the most recent quarter with virtually no billable activity.
The company recorded an operating loss of $64.0 million for the June quarter, a deficit that amounts to approximately 850 times its quarterly sales figures.
By comparison, the S&P 500 as a whole retains around 18.5% of its sales as operating profit, underscoring how far NuScale’s financials sit from conventional benchmarks.
The valuation multiple reflects the revenue collapse rather than investor optimism, with NuScale trading at 209.7 times its trailing twelve-month sales through June, against a multiple of 3.1 times for the broader S&P 500.
Management has pointed to a near-term catalyst that could change the trajectory, projecting that revenue would arrive in 2027 if the company finalizes a contract, according to remarks made on the August 5 call.
The most advanced opportunity remains the RoPower project in Doicesti, Romania, which would deploy six NuScale power modules at a former coal plant site.
Executives highlighted a significant competitive advantage, noting that NuScale is the only small modular reactor company to have received design certification from the U.S. Nuclear Regulatory Commission.
Management also noted that several competing reactor designs depend on a uranium fuel type that is not yet available at commercial scale, which further narrows the competitive field.
Despite those structural advantages, no final agreement had been signed as of the August call, with management indicating the company was waiting for the go-ahead to finalize its contract agreements.
The next financial update is expected on or around November 5, 2026, and the status of the RoPower contract will be the single most important detail investors will be watching for.
Without a signed deal, NuScale remains effectively a cash reserve attached to an idle development operation, continuing to draw down its liquid assets each quarter.
Securing the Romania contract would validate management’s 2027 revenue projection and provide the first concrete signal that the company’s commercial model is moving from design phase into execution.
